Published in Mol Ther Methods Clin Dev on March 09, 2016
Study to Prevent Cartilage Damage Following Acute Knee Injury. | NCT00332254
The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage (2010) 3.59
The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest (2005) 3.56
Prevention of cartilage degeneration in a rat model of osteoarthritis by intraarticular treatment with recombinant lubricin. Arthritis Rheum (2009) 1.94
The role of lubricin in the mechanical behavior of synovial fluid. Proc Natl Acad Sci U S A (2007) 1.94
Physiology of cytokine pathways in rheumatoid arthritis. Arthritis Rheum (2001) 1.61
Helper-dependent adenoviral vectors for gene therapy. Hum Gene Ther (2005) 1.59
Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification. Mol Ther (2003) 1.33
Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). Osteoarthritis Cartilage (2012) 1.30
Osteoarthritis gene therapy. Gene Ther (2004) 1.28
Progress in intra-articular therapy. Nat Rev Rheumatol (2013) 1.24
Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis. J Rheumatol (2000) 1.23
Loss of alpha10beta1 integrin expression leads to moderate dysfunction of growth plate chondrocytes. J Cell Sci (2005) 1.22
Arthritis gene therapy and its tortuous path into the clinic. Transl Res (2013) 1.18
Osteoarthritis. Postgrad Med J (2003) 1.17
Proteoglycan 4 expression protects against the development of osteoarthritis. Sci Transl Med (2013) 1.14
Transgene persistence and cell turnover in the diarthrodial joint: implications for gene therapy of chronic joint diseases. Mol Ther (2007) 1.12
Long-term correction of ornithine transcarbamylase deficiency by WPRE-mediated overexpression using a helper-dependent adenovirus. Mol Ther (2004) 1.12
Quantitative imaging of murine osteoarthritic cartilage by phase-contrast micro-computed tomography. Arthritis Rheum (2013) 1.08
Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees. Arthritis Res Ther (2003) 1.07
Large-scale production of high-quality helper-dependent adenoviral vectors using adherent cells in cell factories. Hum Gene Ther (2010) 1.07
Exogenous insulin-like growth factor-I stimulates an autoinductive IGF-I autocrine/paracrine response in chondrocytes. J Orthop Res (2001) 1.06
Distribution of the collagen-binding integrin alpha10beta1 during mouse development. Cell Tissue Res (2001) 1.02
Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients. Cytotherapy (2012) 0.99
Alpha10 integrin expression is up-regulated on fibroblast growth factor-2-treated mesenchymal stem cells with improved chondrogenic differentiation potential. Stem Cells Dev (2007) 0.98
Getting arthritis gene therapy into the clinic. Nat Rev Rheumatol (2010) 0.94
Coxsackievirus and adenovirus receptor (CAR)-positive immature osteoblasts as targets of adenovirus-mediated gene transfer for fracture healing. Gene Ther (2003) 0.84
Recent developments and current status of gene therapy using viral vectors in the United Kingdom. BMJ (2004) 0.82
Update on osteoarthritis. Med Health R I (1999) 0.82